Celularity Depreciation & Amortization Growth & History (CELU)
Celularity's depreciation and amortization was $7.3M for fiscal 2025.
View full Celularity company overviewCelularity annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $7.3M | −$627,000 | −7.91% |
| 2024 | 2024-12-31 | $7.9M | −$1.4M | −15.04% |
| 2023 | 2023-12-31 | $9.3M | −$112,000 | −1.19% |
| 2022 | 2022-12-31 | $9.4M | $619,000 | +7.02% |
| 2021 | 2021-12-31 | $8.8M | $643,000 | +7.87% |
| 2020 | 2020-12-31 | $8.2M | — | — |
Celularity quarterly depreciation and amortization
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $1.8M | −$73,000 | −3.89% |
| Q3 2025 | 2025-09-30 | $1.8M | $305,000 | +20.08% |
| Q2 2025 | 2025-06-30 | $1.8M | $294,000 | +19.09% |
| Q1 2025 | 2025-03-31 | $1.8M | −$322,000 | −14.94% |
| Q4 2024 | 2024-12-31 | $1.9M | — | — |
| Q3 2024 | 2024-09-30 | $1.5M | −$271,000 | −15.14% |
| Q2 2024 | 2024-06-30 | $1.5M | −$236,000 | −13.29% |
| Q1 2024 | 2024-03-31 | $2.2M | −$207,000 | −8.76% |
| Q3 2023 | 2023-09-30 | $1.8M | −$51,000 | −2.77% |
| Q2 2023 | 2023-06-30 | $1.8M | $3,000 | +0.17% |
| Q1 2023 | 2023-03-31 | $2.4M | $79,000 | +3.46% |
| Q3 2022 | 2022-09-30 | $1.8M | $49,000 | +2.73% |
| Q2 2022 | 2022-06-30 | $1.8M | $388,000 | +28.01% |
| Q1 2022 | 2022-03-31 | $2.3M | $348,000 | +17.98% |
| Q3 2021 | 2021-09-30 | $1.8M | −$503,000 | −21.92% |
| Q2 2021 | 2021-06-30 | $1.4M | — | — |
| Q1 2021 | 2021-03-31 | $1.9M | — | — |
| Q3 2020 | 2020-09-30 | $2.3M | — | — |
Celularity depreciation and amortization trends
Over the last five fiscal years, Celularity's depreciation and amortization decreased from $8.2M to $7.3M, a change of −$879,000. The latest reported quarter, Q4 2025, shows $1.8M.
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Celularity source filings ↗